Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer
Clinical trial NCT00574236 · TERMINATED
Trial details
- NCT number
- NCT00574236
- Sponsor
- University of Wisconsin, Madison
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2009-10-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.